Adventist Health Feather River, also known as Feather River Hospital, is a 101-bed acute care hospital located in the town of Paradise, in Butte County, California, with a wide array of outpatient departments and services designed to meet the health care needs of Paradise, Magalia, and neighboring communities.

There are 101 beds in Feather River Cancer Center.

During the past decade, Feather River Cancer Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 19 clinical trials were completed, i.e. on average, 190% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Feather River Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Feather River Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Feather River Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Lung Cancer" (3 trials), "Breast Cancer" (2 trials) and "Pain" (2 trials). Many other conditions were trialed in "Feather River Cancer Center" in a lesser frequency.

Most popular intervention types in "Feather River Cancer Center" are "Drug" (18 trials), "Other" (13 trials), "Biological" (7 trials), "Radiation" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (5 trials), "Paclitaxel" (4 trials), "Carboplatin" (3 trials) and "Durvalumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Feather River Cancer Center" are 16 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Feather River Cancer Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Feather River Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Feather River Cancer Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".